Publicaciones en colaboración con investigadores/as de Hospital Universitario La Fe (11)

2024

  1. Key steps and barriers in the journey of patients with epilepsy through the National Healthcare System in Spain: The EPIPASS qualitative study

    Epilepsia Open, Vol. 9, Núm. 5, pp. 1731-1744

2023

  1. Proposed Recommendations for the Management of Depression in Adults with Epilepsy: An Expert Consensus

    Neurology and Therapy, Vol. 12, Núm. 2, pp. 479-503

2020

  1. Sleep-related movement and behavioural disorders in adults

    Revista de Neurologia, Vol. 71, Núm. 10, pp. 377-386

2019

  1. BRIVA-LIFE–A multicenter retrospective study of the long-term use of brivaracetam in clinical practice

    Acta Neurologica Scandinavica, Vol. 139, Núm. 4, pp. 360-368

  2. MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy

    Epilepsy and Behavior, Vol. 97, pp. 51-59

2017

  1. EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure

    Acta Neurologica Scandinavica, Vol. 136, Núm. 3, pp. 254-264

  2. Erratum to “Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study” [Epilepsy Res. (2016) 126 (201–210)] (S0920121116301218)(10.1016/j.eplepsyres.2016.08.001)

    Epilepsy Research

2016

  1. Muscle imaging in muscle dystrophies produced by mutations in the EMD and LMNA genes

    Neuromuscular Disorders, Vol. 26, Núm. 1, pp. 33-40

  2. Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study

    Epilepsy Research, Vol. 126, pp. 201-210

2005

  1. LGMD2A: Genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene

    Brain, Vol. 128, Núm. 4, pp. 732-742

1995

  1. Influence of the sex of the transmitting grandparent in congenital myotonic dystrophy

    Journal of Medical Genetics, Vol. 32, Núm. 9, pp. 689-691